Wyeth issues recall/replacement program for children’s cough-cold dispensing cups
MADISON, N.J. In response to concerns voiced by a pair of Food and Drug Administration advisory panel’s concerns over uniformity in dosage delivery devices, Wyeth Consumer Healthcare on Monday announced it has initiated a voluntary recall and replacement program for all U.S. retail outlets that sell several Robitussin products and Children’s Dimetapp Cold & Chest Congestion.
The program involves removal of existing products with a dosage cup that does not have a half-teaspoon mark, which is the recommended dose for children age two to under six. This action is specific to the dosage cup and not related to the medication itself, the company stated. For children age two to under six, the company is advising consumers not to use these medicines until the replacement products with the new cup are available.
The replacement products with the new dosage cup are expected to be available beginning in early November 2007. Packaging for the replacement products will be marked to indicate that the new dosage cup is included.
The recall and replacement program for these products does not affect other Robitussin and Dimetapp cough and cold products.
Products being recalled and replaced include:
- Robitussin Cough DM
- Robitussin Cough & Cold CF
- Robitussin Cough & Congestion
- Robitussin Chest Congestion
- Robitussin Head & Chest Congestion PE
- Robitussin Cough Sugar Free DM
- Children’s Dimetapp Cold & Chest Congestion
NAD recommends ad modifications for Estroven
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that Amerifit Brands modify advertising for its Estroven brand dietary supplement.
NAD examined evidence that included a number of studies on ingredients that found in Estroven, including black cohosh and valerian root. However, NAD determined that in the absence of any testing on the product itself, the advertiser’s “clinically proven” claims for Estroven were unsupported and recommended that they be discontinued.
NAD did, however, find that the totality of the research indicated that these ingredients can “help” accomplish the claimed benefits. Accordingly, NAD recommended that the advertiser discontinue its clinically proven claims, but noted that it may make certain milder, ingredient performance claims—that Estroven contains black cohosh, isoflavones and valerian root, ingredients that may help reduce the symptoms associated with menopause and in the case of valerian root, may help one sleep.
NAD also found that Amerifit provided a reasonable basis to support its sales and preference claims that “Estroven is the No. 1 pharmacist recommended supplement for menopause…” and “Estroven, with clinically proven ingredients, is the No. 1 choice among women for natural support during menopause,” as well as the claim that “Estroven is America’s top-selling women’s dietary supplement.”
Matrixx CEO predicts retailers will stock cough/cold medicines in a timelier manner
PHOENIX The purchase of cough and cold items by retailers may more closely correspond with illness rates going forward as opposed to seeing a significant purchase spike just before the cough and cold season in August, Carl Johnson, president and chief executive officer of Matrixx Initiatives, revealed in a press statement Wednesday regarding Matrixx’ most recent quarterly results.
“Over the past couple of years, we have seen our largest retail customers trim the size of their pre-season purchases—which had generally occurred in August and September—and focus on repurchasing inventory as consumption levels increase during the cold season,” he said. “We expect that trend to continue as the consolidation in the industry and growth of several national chains has allowed retailers to manage inventory at tighter levels and replenish store shelves in a timelier manner. We believe this shift in behavior will spread retail orders over the entire cold season compared to the large early inventory buys in previous years, which were sold down throughout the season.”